Therapeutic ultrasound in ischemic stroke treatment: experimental evidence.

Re-opening of the occluded artery is the primary therapeutic goal in hyper-acute ischemic stroke. Systemic treatment with IV rt-PA has been shown to be beneficial at least in a 3 h 'door to needle' window and is approved within that interval in many countries. Trials of thrombolytic therapy with rt-PA demonstrated a small, but significant improvement in neurological outcome in selected patients. As recently shown, intra-arterial application of rt-PA is effective and opens the therapeutical window to 6 h, but requires invasive intra-arterial angiographic intervention in a high number of patients, who do not finally achieve thrombolysis. Ultrasound (US) is known to have several biological effects depending on the emission characteristics. At higher energy levels US alone has a thrombolytic effect. That effect is already used for clinical purposes in interventional therapy using US catheters. Recently, there is growing evidence that US at lower energy levels (<2 W/cm(2)) facilitates enzymatic mediated thrombolysis, most probably by breaking molecular linkages of fibrin polymers and therefore, increasing the working surface for the thrombolytic drug. Different in-vitro and in-vivo experiments have shown increased clot lysis as well as accelerated recanalization of occluded peripheral, coronary vessels and most recently also intracerebral arteries. Sonothrombolysis at low energy levels, however, is of great interest because of the low risk for collateral tissue damage, enabling external insonation without the need for local catheterization. Whereas little or no attenuation of US can be expected through skin and chest, intensity will be significantly attenuated if penetration of bones, particularly the skull, is required. That effect, however, is frequency dependent. Whereas >90% of intracerebral US intensity is lost (of the output power) in frequencies currently used for diagnostic purposes (mostly 2 MHz and up), that ratio is nearly reversed in the lower KHz range (<300 kHz). US at these low frequencies, however, is efficient for accelerating enzymatic thrombolysis in-vitro as well as in vivo within a wide range of intensities, from 0.5 W/cm(2) (MI approximately 0.3) to several W/cm(2). Since the emitted US beam widens with decreasing frequency, low-frequency US can insonate the entire intracerebral vasculature. That may overcome the limitation of US in the MHz range being restricted to insonation of the MCA mainstem. There are no reports in the preclinical literature about intracerebral bleeding or relevant cerebral cellular damage (either signs of necrosis or apoptosis) for US energy levels up to 1 W/cm(2). Moreover, recent investigations showed no break-down of the blood brain barrier. Safety of US exposure of the brain for therapeutic purposes has to address heating. Heating depends critically on the characteristics of the US. The most significant heating of the brain tissue itself is >1 degrees C/h using a continuous wave (CW) 2 W/cm(2) probe, whereas no significant heating could be found when using an intermittent (pulsed) emission protocol. The experimental data so far help to characterize the optimal US settings for sonothrombolysis and support the hypothesis that this combined treatment is a prospective advance in optimizing thrombolytic therapy in acute stroke.

[1]  S. Greenberg Cerebral Amyloid Angiopathy and Vessel Dysfunction , 2002, Cerebrovascular Diseases.

[2]  S. Edgar,et al.  The augmentation of leucocyte adhesion to endothelium by therapeutic ultrasound. , 1994, Ultrasound in medicine & biology.

[3]  R. Apfel Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. , 1982, The British journal of cancer. Supplement.

[4]  C. Francis,et al.  Acceleration of fibrinolysis by ultrasound in a rabbit ear model of small vessel injury. , 1994, Thrombosis research.

[5]  H. Furuhata,et al.  Can Transcranial Ultrasonication Increase Recanalization Flow With Tissue Plasminogen Activator? , 2001, Stroke.

[6]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[7]  W. Hacke,et al.  Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. , 1988, Stroke.

[8]  C. Francis,et al.  Effect of 40-kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion. , 2000, Circulation.

[9]  R S Meltzer,et al.  Ultrasound accelerates urokinase-induced thrombolysis and reperfusion. , 1994, American heart journal.

[10]  A. Bozzao,et al.  Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. , 1989, Stroke.

[11]  C. Francis,et al.  Ultrasound enhancement of rabbit femoral artery thrombolysis. , 1997, Cardiovascular surgery.

[12]  C G Lauer,et al.  Effect of Ultrasound on Tissue‐Type Plasminogen Activator‐Induced Thrombolysis , 1992, Circulation.

[13]  K. Tachibana,et al.  Enhancement of fibrinolysis with ultrasound energy. , 1992, Journal of vascular and interventional radiology : JVIR.

[14]  C. Francis,et al.  Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. , 1995, Ultrasound in medicine & biology.

[15]  R. Marshall,et al.  Current management of ischaemic stroke. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[16]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[17]  H. Hopf,et al.  Low‐Frequency Ultrasound Induces Nonenzymatic Thrombolysis In Vitro , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[18]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[19]  R E Apfel,et al.  Direct evidence of cavitation in vivo from diagnostic ultrasound. , 1996, Ultrasound in medicine & biology.

[20]  P. T. Onundarson,et al.  Enhancement of fibrinolysis in vitro by ultrasound. , 1992, The Journal of clinical investigation.

[21]  J. Barger,et al.  Acoustical properties of the human skull. , 1978, The Journal of the Acoustical Society of America.

[22]  M. Hennerici,et al.  Acceleration of thrombolysis with ultrasound through the cranium in a flow model. , 2000, Ultrasound in medicine & biology.

[23]  A. Yamadori,et al.  Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke , 1992, Neurology.

[24]  D. Clement A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[25]  Z. Vered,et al.  Does external ultrasound accelerate thrombolysis? Results from a rabbit model. , 1994, Circulation.

[26]  C. Francis,et al.  Enhancement of fibrinolysis with 40-kHz ultrasound. , 1998, Circulation.

[27]  R S Meltzer,et al.  Hemolysis in vivo from exposure to pulsed ultrasound. , 1997, Ultrasound in medicine & biology.

[28]  W. Hacke,et al.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.

[29]  F. Fry,et al.  Transkull focal lesions in cat brain produced by ultrasound. , 1981, Journal of neurosurgery.

[30]  M. Fishbein,et al.  Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study. , 1997, Journal of the American College of Cardiology.

[31]  R. Siegel,et al.  Ultrasound recanalization of diseased arteries. From experimental studies to clinical application. , 1992, The Surgical clinics of North America.

[32]  H. Furuhata,et al.  Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasonic irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. , 1994, Biological & pharmaceutical bulletin.

[33]  R. Siegel,et al.  Percutaneous peripheral ultrasonic angioplasty. , 1990, Herz.

[34]  P. Akins,et al.  Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.

[35]  M. Hennerici,et al.  Low-frequency, low-intensity ultrasound accelerates thrombolysis through the skull. , 1999, Ultrasound in medicine & biology.

[36]  M. Goyen,et al.  Intravascular ultrasound angioplasty in peripheral arterial occlusion: Preliminary experience , 2000, Acta radiologica.

[37]  M. Fishbein,et al.  Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. , 1998, Thrombosis research.

[38]  A. R. Williams,et al.  Release of β‐Thromboglobulin from Human Platelets by Therapeutic Intensities of Ultrasound , 1978, British journal of haematology.

[39]  R. Aaslid,et al.  Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. , 1982, Journal of neurosurgery.

[40]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[41]  H. Furuhata,et al.  Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. , 1998, Neurosurgery.

[42]  M. Dyson,et al.  The effect of therapeutic ultrasound on calcium uptake in fibroblasts. , 1988, Ultrasound in medicine & biology.

[43]  A. Thie,et al.  Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA) , 2004, Neuroradiology.

[44]  M. Fishbein,et al.  Transcutaneous ultrasound augments lysis of arterial thrombi in vivo. , 1996, Circulation.

[45]  K. Hamano Thrombolysis enhanced by transcutaneous ultrasonic irradiation , 1991 .

[46]  M. Dennis A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .